CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million
CALGARY, AB, Dec. 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- CannaPharmaRx, Inc. (OTC PINK:CPMD)(the “Company”), an emerging leader in development and operation of ultramodern, highly eff...